Search results
Sarasota hospital board bucks Ladapo's claims against COVID-19 vaccines
WUSF 89.7· 5 days agoSarasota Memorial Health Care System will not endorse Florida Surgeon General Joseph Ladapo's guidance against COVID-19 vaccines on its ...
Trump, accustomed to friendly crowds, confronts repeated booing during Libertarian convention speech...
Chattanooga Times Free Press· 48 minutes agoDonald Trump was booed repeatedly while addressing the Libertarian Party National Convention on...
Better Buy: Inovio Pharmaceuticals vs. Novavax | The Motley Fool
The Motley Fool· 5 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 7 days agoFEATURE U.S. vaccine makers say that the Food and Drug Administration’s delay in designing this...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters via AOL· 3 days agoNovavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators...
Cary firm part of $5B federal program to develop Covid-19 vaccines - Triad Business Journal
The Business Journals· 6 days agoThe federal government has selected a contract research organization in the Triangle to lead part of...
Vaccines lower risk of long COVID: Study
The Hill· 4 days agoA new study has found that patients vaccinated against the COVID-19 virus were less likely to experience symptoms of post-COVID condition, or long COVID...
Could current COVID vaccines protect against future outbreaks? New study offers hope
Orange County Register· 4 days agoA group of researchers had the future in mind when they asked if current COVID-19 vaccines and...
Trump booed and heckled by raucous crowd at Libertarian convention - BusinessWorld Online
BusinessWorld· 12 hours agoLibertarians, who believe in limited government and individual freedom, blame Mr. Trump, a...
Should You Buy This Stock After a Regulatory Setback?
Motley Fool via Yahoo Finance· 1 day agoThe past two-and-a-half years have been rough for Moderna (NASDAQ: MRNA). Though the biotech was...